Recruiting
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
NCT07342478
- Conditions
- CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +23 more
- Locations
-
- The Center for Cancer and Blood Disorders-Bethesda Bethesda, Maryland, United States
- Optum Medical Group (Rhodes) P.C. Las Vegas, Nevada, United States
- OSU Comprehensive Cancer Center Columbus, Ohio, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States